Bristol Myers Squibb

Bristol Myers Squibb At Bristol Myers Squibb, we work every day to transform patients’ lives through science.

09/02/2026

Living with cancer, including , impacts every area of life, from physical health to emotional and social well-being. With the recent approval of a new treatment option for eligible patients, we’re reminded that meaningful care includes both medical innovation and practical support for everyday life.

Because navigating cancer involves many dimensions of daily life, that’s why we’re launching Thriving Through Multiple Myeloma in partnership with Thrive Global, founded by Arianna Huffington. This free well-being resource offers tools to help manage stress and establish healthy habits that support long-term care.

Explore the resource hub and discover practical support for navigating life with multiple myeloma: https://bit.ly/3V96AJF

09/01/2026

Every three minutes, someone is diagnosed with a form of blood cancer in the U.S. Each diagnosis represents a parent, family member, a colleague or friend navigating this change.

This September, we recognize and the resilience of those living with blood cancers.

We see your courage, we hear your stories and we promise to keep fighting for a better tomorrow.

https://bit.ly/3SET0Nu

09/01/2026

We’ve been researching potential therapies for people living with pulmonary fibrosis (PF) for more than a decade, and we’re building on that progress every day.

While available therapies can help slow decline in lung function, many people continue to face ongoing challenges, underscoring the need for new approaches that may help preserve quality of life and daily function.

During Pulmonary Fibrosis Awareness Month, learn more about our approach to research in pulmonary fibrosis: https://bit.ly/4zNDVKg

The FDA recently approved a new treatment for certain patients with multiple myeloma and introduced a new class of treat...
08/19/2026

The FDA recently approved a new treatment for certain patients with multiple myeloma and introduced a new class of treatment.

This treatment may help address the needs of adult patients living with this disease, as early as first relapse.

Learn more about multiple myeloma: https://bit.ly/4gpCtop

08/13/2026

New update for the community. The FDA has approved our new CELMoD treatment for certain patients with multiple myeloma.

CELMoD represents a promising therapeutic option to fight multiple myeloma as early as first relapse for patients with this challenging disease. https://bit.ly/4xyIUMW

For more than 25 years, the Bristol Myers Squibb Foundation (BMS Foundation), an independent charitable organization, ha...
08/12/2026

For more than 25 years, the Bristol Myers Squibb Foundation (BMS Foundation), an independent charitable organization, has worked alongside its local grantee partners across sub-Saharan Africa to strengthen health systems and help expand access to care.

The impact comes to life through stories like those of Francis, who received a lung cancer diagnosis that led to life-changing care, Beatrice, who received cervical cancer screening in her own community, and continent-wide efforts to improve care for children living with cancer and sickle cell disease.

Through locally led solutions, the BMS Foundation and its grantee partners are helping build stronger, more sustainable systems of care designed to reach more people today and endure for generations.

Learn more about the BMS Foundation and its work to improve access to care across sub-Saharan Africa: https://bit.ly/4i2IR7p

08/07/2026

Mental health advocates like Maria know how stressful caregiving for patients with schizophrenia can be, especially when the patient is your mother. See how she turned her family’s pain into Kompashion, a platform to eliminate barriers to mental health services for Latino communities, and how it inspired our mission to drive better outcomes for patients and their loved ones: https://bit.ly/3TI0gIC

07/31/2026

“All you need to get lung cancer is a set of lungs.”

Here's something a lot of people don't realize: while to***co remains the leading risk factor, most people diagnosed with lung cancer today have either quit smoking years ago or never smoked at all. That disconnect between perception and reality can follow a patient throughout their entire treatment journey, making it harder for them to find the empathy, support and care they deserve.

As we prepare to observe tomorrow, hear from our SVP and head of Global Medical Oncology, Dr. Nate Pennell, as he draws on his own experience to talk about why addressing this bias is so important — for patients, for families and for progress against the disease.

Watch the full conversation here: https://bit.ly/4ww7xd1

07/23/2026

Our Kickoff for Community Health during the World Cup was more than just a moment. Community health is built through access, trust and connection. Alongside our community partners, we stand united to foster spaces and resources where families can create healthy habits, connect with health resources and feel supported at home.

Often misunderstood, Sjögren’s disease goes beyond dry eyes and mouth. It’s a systemic condition that can impact multipl...
07/23/2026

Often misunderstood, Sjögren’s disease goes beyond dry eyes and mouth. It’s a systemic condition that can impact multiple parts of the body and daily life. With symptoms that vary widely, diagnosis and care can be challenging, and current treatments are largely symptom focused.

We’re looking beyond symptom management by focusing on understanding the biology of the disease, so that we can advance potential new treatment options.

Learn more about Sjögren’s disease: https://bit.ly/4bLSQtO

Address

Route 206 & Province Line Road
Princeton, NJ
08543

Website

,

Alerts

Be the first to know and let us send you an email when Bristol Myers Squibb posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category